Sign inJoin
Company / Finance

Cardinal Health, Inc.

CAH · NYSE

CAH has an annual revenue baseline of $222.6B, latest revenue marker of $129.6B first half fiscal 2026 companyfacts frame, annual net income of $1.6B and cash of $2.8B latest companyfacts cash frame. The thesis depends on revenue durability, margins, cash conversion and balance-sheet discipline.

FollowAdd to WatchlistAsk Question
NYSECAHCoverage BootstrapCardinal Health, Inc.
Latest ReportMay 20, 2026Cardinal Health: huge drug-distribution scale still has to prove margin and balance-sheet qualityView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->
Company filters1 of 1 reports match
Clear filters
Selected tags
NYSECoverage Bootstrap
Clear tags
MatchAny tagAll tags
Latest Thesis

Cardinal Health: huge drug-distribution scale still has to prove margin and balance-sheet quality

CAH has an annual revenue baseline of $222.6B, latest revenue marker of $129.6B first half fiscal 2026 companyfacts frame, annual net income of $1.6B and cash of $2.8B latest companyfacts cash frame. The thesis depends on revenue durability, margins, cash conversion and balance-sheet discipline.

May 20, 2026Research reportSlides available
Read reportOpen slidesDiscussion (0)
Cardinal Health, Inc.Health: huge drug-distribution scale still has to prove margin aMay 20, 2026
Member workspace

Financials and workspace tools are for paid members.

Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.

Sign in to continue

Recent Reports

Compact report index for this company.

View all 1 reports ->
ReportTypeUpdatedReadActions
Cardinal Health: huge drug-distribution scale still has to prove margin and balance-sheet qualityCAH has an annual revenue baseline of $222.6B, latest revenue marker of $129.6B first half fiscal 2026 companyfacts frame, annual net income of $1.6B and cash of $2.8B latest companyfacts cash frame. The thesis depends on revenue durability, margins, cash conversion and balance-sheet discipline.NYSEMay 20, 2026Research reportReadSlides